Order of the National Green Tribunal in the matter of In Re: News Item titled "Nayar river is vanishing - a yatra reveals conservation goes beyond science and policy" appearing in ‘The Down To Earth’ dated 03.06.2025. The original application was registered suo-motu based on the news item titled "Nayar …
The Supreme Court on Monday directed the Union health ministry to make drug companies that want to experiment with new formulations answer three queries in a format to be prepared by the technical committee. The pharmaceutical companies must specify whether the risk involved in testing the new formulations on human …
New Delhi : Expressing concern over deaths and serious injuries to patients during clinical trials of new chemical entities, the Supreme Court on Monday asked the government to “compel” the sponsor companies of such trials to pay compensation to the affected. “Why don't you (government) compel the sponsor (of clinical …
Calls for revision of World Health Organization’s list of carcinogens, says not enough data to establish the link. India-born oncologist Dr Siddhartha Mukherjee on Monday urged World Health Organization to remove cellphone radiation from the list of carcinogens on the ground that the “preponderance of evidence suggests there is no …
NEW DELHI: After ensuring that multinational pharmaceutical majors compensate those who die during clinical trials of their new drugs, the Supreme Court on Monday pulled up the Centre for not forcing the sponsors to provide similar relief to those suffering serious adverse effects during such trials. Taking up PILs seeking …
The death of 254 Indian women in the course of a 15-year US-funded clinical trial has triggered a raging debate about its ethicality. The trial was for a cervical cancer screening method and the women who died were part of a control group kept without screening to study death rates …
Pharma companies must specify whether risk involved in testing new formulations on human beings justified by benefits expected from exercise The Supreme Court today directed the Union Health Ministry to make drug companies, which want to experiment with new formulations, to answer three queries in a format to be prepared …
India is facing a cancer crisis, with smoking, belated diagnosis and unequal access to treatment causing large-scale problems, experts have said. Every year in India, around one million new cancer cases are diagnosed and around 600,000 to 700,000 people die from cancer in India, with this death toll projected to …
Scientists have found that the two drugs used across the world to treat swine flu — Tamiflu and Relenza — are no better than Paracetamol in relieving flu symptoms and are next to useless in preventing a pandemic. Many countries including India have spent millions of dollars in stockpiling these …
Latest estimates announced on Friday have revealed some worrying findings about the growing burden of cancer in India. The latest figures published in the British medical journal The Lancet show that around one million new cancer cases are being diagnosed in India each year, projected to nearly double to 1.7 …
The govt as well as the central drug regulatory agency have been cautious on approving any clinical trial after SC instructions Proposals from leading pharmaceutical companies such as Novo Nordisk, Cadila Pharmaceuticals, Wockhardt, Novartis, Roche and Reliance Life Sciences for conducting clinical trials were recently rejected by a regulatory committee, …
Researchers have suggested that people with a genetic predisposition to obesity are at a higher risk of obesity and related chronic diseases from eating fried foods than those with a lower genetic risk. Lu Qi, lead author and assistant professor in the Department of Nutrition at HSPH and Brigham and …
The decline in the number of clinical trials in India has the authorities worried. The Drug Controller General of India (DCGI) has, therefore, decided to lift the cap on the number of clinical trials an investigator can conduct. Earlier experts had made it mandatory that there should not be more …
The Supreme Court on Monday directed the centre to provide details on the number of deaths and severe adverse effects caused to people who were subjected to clinical trials. A bench headed by Justice R M Lodha expressed concern over the issue, saying the government must take a balanced approach …
Telangana Bill scheduled to be taken up for discussion in Parliament tomorrow The Andhra Pradesh government on Monday unveiled an exclusive policy for the lifesciences sector with a mission mode approach over the next five year at the inaugural session of the annual edition of BioAsia summit here. The policy …
Contrary to the popular belief that India is becoming dumping ground for clinical trials, the recent data, in fact, shows that the number of clinical trials are on a downward spiral. As per the government data, in 2011 the Drug Controller General of India (DCGI) received 306 applications for approval …
Union health minister Ghulam Nabi Azad on Wednesday said that there is a need to strike balance between the interests of all the stakeholders with regard to the country’s regulatory policy on clinical trials, noting that innovation should be encouraged. Pharma firms have complained that India's new regulations for clinical …
Pune: There is better awareness about genetic testing for cancer in the city. Within a month of its launch, the first counselling centre set up in a city hospital to advise people on whether or not they need to take genetic tests has seen eight families with a strong family …
Indian Council of Medical Research (ICMR) has washed its hands of the clinical drug trials that took place on gas-victims at Bhopal Memorial Hospital and Research Centre (BMHRC). Some of the doctors allegedly involved in these trials have resigned from BMHRC in the past few weeks. According to ICMR director …
The new draft protocol for clinical trials of drugs, on the lines suggested by the Supreme Court, is making it difficult for global drug manufacturers to find subjects for testing new chemical compositions. The protocol has made it mandatory for companies intending to conduct human trials of drugs to video-record …
The Drug Controller General of India (DCGI) has released draft guidelines that make it mandatory for clinical research organisations to conduct an audiovisual recording of the trial patients informing them about each and every risk involved while undergoing the trial. The measure, introduced in addition to the existing written consent …
